The p53 pathway in breast cancer
p53 mutation remains the most common genetic change identified in human neoplasia. In breast cancer, p53 mutation is associated with more aggressive disease and worse overall survival. The frequency of mutation in p53 is, however, lower in breast cancer than in other solid tumours. Changes, both gen...
Main Authors: | Gasco, Milena, Shami, Shukri, Crook, Tim |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2002
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138723/ |
Similar Items
-
The p53 Pathway in Glioblastoma
by: Ying Zhang, et al.
Published: (2018-09-01) -
Drug discovery in the p53 pathway
by: Lane, DP, et al.
Published: (2000) -
Differential regulation of the REGγ–proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells
by: Ali, Amjad, et al.
Published: (2013) -
Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment
by: Hrstka, Roman, et al.
Published: (2009) -
p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
by: Bourdon, Jean-Christophe, et al.
Published: (2011)